Endevica Bio's Chief Medical and Scientific Officer, Dr. Daniel Marks, discusses the origin of his determination to find a cure for cachexia, a metabolic syndrome that leads to loss of body weight and muscle mass in patients with cancer and other chronic diseases. The Endevica team is developing a drug that shows significant promise. #Cachexia #InnovativeTreatment #CachexiaResearch #HealthInnovation #Cancer
Endevica Bio
Biotechnology Research
Columbia, Missouri 1,112 followers
Reversing cachexia and improving quality of life in cancer patients. Phase 1 trial underway.
About us
Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
- Website
-
http://www.endevicabio.com
External link for Endevica Bio
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Columbia, Missouri
- Type
- Privately Held
- Founded
- 2009
- Specialties
- Peptides, Drug Design, Drug Delivery, Cachexia, and Drug Development
Locations
-
Primary
Get directions
1601 S Providence Rd
Columbia, Missouri 65211, US
Employees at Endevica Bio
Updates
-
At Endevica Bio, we are excited to develop a drug to treat cachexia, a debilitating wasting syndrome. Current approaches to manage cachexia are limited, and a successful treatment could revolutionize care for those suffering from the condition, improving treatment outcomes and quality of life. #Cachexia #Cancer #Healthcare #Innovation Read more below:
Hope for Cancer Patients
Endevica Bio on LinkedIn
-
Endevica Bio CEO Russell Potterfield discusses why hiring in groups brings significant benefits. Read the full article here: https://lnkd.in/eMjEgWRK #Hiring #GrowYourTeam #Cachexia #MedicalResearch #Innovation
At Endevica Bio, we strongly believe hiring two, three or more people at the same time helps foster camaraderie, collaboration and growth. Read more below:
Why We Hire in Groups
Russell Potterfield on LinkedIn
-
We’re thrilled to announce our novel weight-loss treatment was successful in a recent diet-induced obesity rat study. Exciting times are ahead for our team as we continue to innovate. Read more below: https://lnkd.in/efqrfk6F
Endevica Bio drug candidate shows success in weight loss in new study
prnewswire.com